AI is Accelerating Drug Discovery: McKernan
SV Health Investors’ Ruth McKernan says wearables and health data are helping move medicine from the general to the personal. She says AI is already speeding up parts of drug discovery and improving patient selection for clinical trials. But McKernan says some parts of development cannot be rushed, and the UK still needs more funding to help life-sciences companies scale. She spoke to Tom…
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
